This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
NPK Q2 Earnings Down Y/Y As Tariffs Weigh, Sales up 42%
by Zacks Equity Research
National Presto's Q2 earnings gain on 41.6% sales growth driven by Defense, but net income dropped 15% due to tariffs and supplier-related losses.
The Zacks Analyst Blog Highlights Alphabet, IBM, RTX and National Presto Industries
by Zacks Equity Research
NPK's defense-driven growth, cloud momentum at Alphabet, and IBM's AI push headline Zacks' top analyst picks today.
Top Research Reports for Alphabet, IBM & RTX
by Mark Vickery
GOOGL, IBM and RTX lead today's Zacks research, with AI, cloud, and defense backlogs fueling strong long-term prospects.
NPK Stock Down 8% Despite Q1 Earnings Rise Y/Y on Higher Defense Sales
by Zacks Equity Research
National Presto reports strong year-over-year growth in Q1 earnings, driven by military demand, higher shipments and segment-wide sales growth, despite headwinds from steep tariffs.
The Zacks Analyst Blog Roche Holding, Comcast, Eaton Corp and National Presto Industries
by Zacks Equity Research
Roche Holding, Comcast, Eaton Corp and National Presto Industries are included in this Analyst Blog.
Top Analyst Reports for Roche, Comcast & Eaton
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Comcast Corp. (CMCSA) and Eaton Corp. plc (ETN), as well as two micro-cap stocks National Presto Industries, Inc. (NPK) and Cemtrex, Inc. (CETX).
National Presto Posts 20% Y/Y Earnings Growth in 2024 on Defense Backlog
by Zacks Equity Research
NPK's 2024 EPS witnesses 20% year-over-year growth, driven by strong Defense sales, improved retail demand and a better product mix. A $1 billion backlog limits extra dividends for 2025.
The Zacks Analyst Blog Highlights AstraZeneca, Accenture, AT&T and National Presto Industries
by Zacks Equity Research
AstraZeneca, Accenture, AT&T and National Presto Industries are part of the Zacks top Analyst Blog.
Top Research Reports for AstraZeneca, Accenture & AT&T
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Accenture plc (ACN) and AT&T Inc. (T), as well as a micro-cap stock National Presto Industries, Inc. (NPK).
The Zacks Analyst Blog Highlights Optex Systems, Frequency Electronics, Servotronics, Sypris Solutions and National Presto
by Zacks Equity Research
Optex Systems, Frequency Electronics, Servotronics, Sypris Solutions and National Presto are included in this Analyst Blog.
5 Microcaps with Exposure to Defense Spending
by Mark Zinski
Global defense spending is perking up and these 5 microcaps may benefit.
National Presto's (NPK) Q2 EPS Rises Y/Y on Defense Growth
by Zacks Equity Research
National Presto (NPK) reports a 7.7% year-over-year sales increase in Q2 2024, driven by strong performance in the Defense segment, despite challenges in Housewares.
Zacks Initiates Coverage of National Presto With Neutral Recommendation
by Debasmita Chatterjee
Discover why Zacks rates National Presto with a "Neutral" recommendation, being the first on Wall Street to initiate coverage on the stock. Uncover its financial strength, strategic market positioning and growth potential against key challenges in the defense and kitchen appliances sectors.
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Advanced Micro Devices, PepsiCo, SAP SE, FitLife Brands and National Presto Industries
by Zacks Equity Research
Advanced Micro Devices, PepsiCo, SAP SE, FitLife Brands and National Presto Industries are included in this Analyst Blog.
Top Analyst Reports for AMD, PepsiCo & SAP
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), PepsiCo, Inc. (PEP) and SAP SE (SAP), as well as two micro-cap stocks FitLife Brands, Inc. (FTLF) and National Presto Industries, Inc. (NPK).